Affordable Access

Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.

Authors
Type
Published Article
Journal
Molecular medicine (Cambridge, Mass.)
Publication Date
Volume
6
Issue
3
Pages
165–178
Identifiers
PMID: 10965493
Source
Medline

Abstract

These results suggest that IL-4(38-37)-PE38KDEL may be a useful agent for targeting of IL-4 receptor positive human breast carcinomas and further studies should be performed to explore fully its potential.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments